What Does 2024 Hold For Biopharma? Treehill Partners featured in Scrip

What Does 2024 Hold For Biopharma? Treehill Partners featured in Scrip

Treehill Partners featured amongst prominent KOLs in Part 2 of Scrip’s 2024 biopharma outlook interview, discussing funding environment, M&A, and partnering.

Read the article on Scrip:

https://scrip.citeline.com/SC149635/Scrip-AsksWhat-Does-2024-Hold-For-Biopharma-Part-2-The-Funding-Environment-MA-And-Partnering

Subscribe to our mailings!

Thank You

Please choose your subscriptions:

Unsubscribe any time using the footer of our emails. For information about our privacy practices, please visit our privacy policy.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.